Kidney, limb and ophthalmic complications, and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: an electronic health record analysis

Olivia S. Costaa Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA;b Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA

Bridget O’Donnella Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA

Burcu Vardarc Bayer AG, Berlin, Germany

Khaled Abdelgawwadc Bayer AG, Berlin, Germany

Christopher W. Bresciad Department of Data Science, Freshtech IT, LLC, East Hartford, CT, USA

Nitesh Soode Arrhythmia Services, Southcoast Health, Fall River, MA, USA

Craig I. Colemana Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA;b Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USACorrespondence[email protected]

https://orcid.org/0000-0003-4868-7158

show all

Kidney, limb and ophthalmic complications, and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: an electronic health record analysis

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Kidney, limb and ophthalmic complications, and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: an electronic health record analysis

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date